{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:41:14Z","timestamp":1790109674055,"version":"4.0.1"},"reference-count":142,"publisher":"Elsevier","isbn-type":[{"value":"9780323950572","type":"print"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003397","name":"Huazhong University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015640","name":"Tongji Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015640","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81790624"],"award-info":[{"award-number":["81790624"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900341"],"award-info":[{"award-number":["81900341"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/bs.apha.2022.11.001","type":"book-chapter","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T07:25:54Z","timestamp":1671521154000},"page":"167-200","source":"Crossref","is-referenced-by-count":6,"title":["The roles of eicosanoids in myocardial diseases"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.apha.2022.11.001_bb0010","series-title":"Cardiac Imaging","first-page":"265","article-title":"Chapter 9\u2014Pericardial and myocardial disease","author":"Abbara","year":"2009"},{"issue":"2","key":"10.1016\/bs.apha.2022.11.001_bb0015","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1073\/pnas.0811022106","article-title":"Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy","volume":"106","author":"Ai","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.apha.2022.11.001_bb0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3389\/fphar.2016.00133","article-title":"Inhibition of soluble epoxide hydrolase limits mitochondrial damage and preserves function following ischemic injury","volume":"7","author":"Akhnokh","year":"2016","journal-title":"Frontiers in Pharmacology"},{"issue":"6","key":"10.1016\/bs.apha.2022.11.001_bb0025","first-page":"144","article-title":"Higher Epoxyeicosatrienoic acids in cardiomyocytes-specific CYP2J2 transgenic mice are associated with improved myocardial remodeling","volume":"8","author":"Aliwarga","year":"2020","journal-title":"Biomedicine"},{"issue":"8","key":"10.1016\/bs.apha.2022.11.001_bb0030","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1111\/bph.12066","article-title":"Soluble epoxide hydrolase inhibitor, TUPS, protects against isoprenaline-induced cardiac hypertrophy","volume":"168","author":"Althurwi","year":"2013","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"10.1016\/bs.apha.2022.11.001_bb0035","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S1734-1140(10)70311-X","article-title":"Cytochrome P450-dependent metabolism of omega-6 and omega-3 long-chain polyunsaturated fatty acids","volume":"62","author":"Arnold","year":"2010","journal-title":"Pharmacological Reports"},{"issue":"7","key":"10.1016\/bs.apha.2022.11.001_bb0040","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/07853890600982737","article-title":"Leukotriene receptors in atherosclerosis","volume":"38","author":"Back","year":"2006","journal-title":"Annals of Medicine"},{"issue":"4","key":"10.1016\/bs.apha.2022.11.001_bb0045","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/med.20098","article-title":"Novel cyclooxygenase-catalyzed bioactive prostaglandin F2alpha from physiology to new principles in inflammation","volume":"27","author":"Basu","year":"2007","journal-title":"Medicinal Research Reviews"},{"issue":"4","key":"10.1016\/bs.apha.2022.11.001_bb0050","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1476-5381.2010.01093.x","article-title":"Cardioprotective effect of a dual acting epoxyeicosatrienoic acid analogue towards ischaemia reperfusion injury","volume":"162","author":"Batchu","year":"2011","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2022.11.001_bb0055","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12872-016-0384-2","article-title":"Electrocardiographic and echocardiographic predictors of paroxysmal atrial fibrillation detected after ischemic stroke","volume":"16","author":"Baturova","year":"2016","journal-title":"BMC Cardiovascular Disorders"},{"issue":"3","key":"10.1016\/bs.apha.2022.11.001_bb0060","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.yjmcc.2010.11.013","article-title":"Inhibition of leukotriene C4 action reduces oxidative stress and apoptosis in cardiomyocytes and impedes remodeling after myocardial injury","volume":"50","author":"Becher","year":"2011","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"17","key":"10.1016\/bs.apha.2022.11.001_bb0065","doi-asserted-by":"crossref","first-page":"11660","DOI":"10.1074\/jbc.274.17.11660","article-title":"Arachidonic acid is preferentially metabolized by cyclooxygenase-2 to prostacyclin and prostaglandin E2","volume":"274","author":"Brock","year":"1999","journal-title":"The Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/bs.apha.2022.11.001_bb0070","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1194\/jlr.R900004-JLR200","article-title":"Thematic review series: Proteomics. An integrated omics analysis of eicosanoid biology","volume":"50","author":"Buczynski","year":"2009","journal-title":"Journal of Lipid Research"},{"issue":"5","key":"10.1016\/bs.apha.2022.11.001_bb0075","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1194\/jlr.M036533","article-title":"CYP2J2 overexpression increases EETs and protects against angiotensin II-induced abdominal aortic aneurysm in mice","volume":"54","author":"Cai","year":"2013","journal-title":"Journal of Lipid Research"},{"issue":"3","key":"10.1016\/bs.apha.2022.11.001_bb0080","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/01.RES.0000054201.60308.1A","article-title":"High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor-alpha content and enhancing prostaglandin release","volume":"92","author":"Calabresi","year":"2003","journal-title":"Circulation Research"},{"issue":"3","key":"10.1016\/bs.apha.2022.11.001_bb0085","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1042\/EBC20190083","article-title":"Eicosanoids","volume":"64","author":"Calder","year":"2020","journal-title":"Essays in Biochemistry"},{"key":"10.1016\/bs.apha.2022.11.001_bb0090","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.prostaglandins.2015.01.002","article-title":"Agonists of epoxyeicosatrienoic acids reduce infarct size and ameliorate cardiac dysfunction via activation of HO-1 and Wnt1 canonical pathway","volume":"116\u2013117","author":"Cao","year":"2015","journal-title":"Prostaglandins & Other Lipid Mediators"},{"issue":"3","key":"10.1016\/bs.apha.2022.11.001_bb0095","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1073\/pnas.79.3.767","article-title":"Cytochrome P-450-dependent oxygenation of arachidonic acid to hydroxyicosatetraenoic acids","volume":"79","author":"Capdevila","year":"1982","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"10.1016\/bs.apha.2022.11.001_bb0100","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/med.20071","article-title":"Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: Critical update and emerging trends","volume":"27","author":"Capra","year":"2007","journal-title":"Medicinal Research Reviews"},{"issue":"1","key":"10.1016\/bs.apha.2022.11.001_bb0105","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/FJC.0b013e3181c37d69","article-title":"Inhibition of soluble epoxide hydrolase by trans-4- [4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is protective against ischemia-reperfusion injury","volume":"55","author":"Chaudhary","year":"2010","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2022.11.001_bb0110","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/cvr\/cvp134","article-title":"Role of B-type natriuretic peptide in epoxyeicosatrienoic acid-mediated improved post-ischaemic recovery of heart contractile function","volume":"83","author":"Chaudhary","year":"2009","journal-title":"Cardiovascular Research"},{"issue":"8","key":"10.1016\/bs.apha.2022.11.001_bb0115","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1074\/jbc.274.8.4764","article-title":"Transfection of an active cytochrome P450 arachidonic acid epoxygenase indicates that 14,15-epoxyeicosatrienoic acid functions as an intracellular second messenger in response to epidermal growth factor","volume":"274","author":"Chen","year":"1999","journal-title":"The Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/bs.apha.2022.11.001_bb0120","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1042\/EBC20190082","article-title":"Oxidation of polyunsaturated fatty acids to produce lipid mediators","volume":"64","author":"Christie","year":"2020","journal-title":"Essays in Biochemistry"},{"issue":"3","key":"10.1016\/bs.apha.2022.11.001_bb0125","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0735-1097(99)00630-0","article-title":"Cardiac remodeling\u2014concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling. Behalf of an international forum on cardiac remodeling","volume":"35","author":"Cohn","year":"2000","journal-title":"Journal of the American College of Cardiology"},{"issue":"5813","key":"10.1016\/bs.apha.2022.11.001_bb0130","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/291323a0","article-title":"Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmias","volume":"291","author":"Coker","year":"1981","journal-title":"Nature"},{"issue":"9","key":"10.1016\/bs.apha.2022.11.001_bb0135","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1002\/jcp.24939","article-title":"Epoxyeicosatrienoic acids regulate macrophage polarization and prevent LPS-induced cardiac dysfunction","volume":"230","author":"Dai","year":"2015","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/bs.apha.2022.11.001_bb0140","doi-asserted-by":"crossref","first-page":"46743","DOI":"10.1038\/srep46743","article-title":"CYP2J2 and its metabolites EETs attenuate insulin resistance via regulating macrophage polarization in adipose tissue","volume":"7","author":"Dai","year":"2017","journal-title":"Scientific Reports"},{"issue":"3","key":"10.1016\/bs.apha.2022.11.001_bb0145","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/cvr\/cvv224","article-title":"BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury","volume":"108","author":"de Hoog","year":"2015","journal-title":"Cardiovascular Research"},{"key":"10.1016\/bs.apha.2022.11.001_bb0150","first-page":"1729","article-title":"Transverse aortic constriction in mice","volume":"38","author":"deAlmeida","year":"2010","journal-title":"Journal of Visualized Experiments"},{"issue":"9","key":"10.1016\/bs.apha.2022.11.001_bb0155","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1161\/01.RES.87.9.781","article-title":"Autonomous and growth factor-induced hypertrophy in cultured neonatal mouse cardiac myocytes. Comparison with rat","volume":"87","author":"Deng","year":"2000","journal-title":"Circulation Research"},{"issue":"8","key":"10.1016\/bs.apha.2022.11.001_bb0160","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/CIRCRESAHA.118.314665","article-title":"Diabetic cardiomyopathy","volume":"124","author":"Dillmann","year":"2019","journal-title":"Circulation Research"},{"key":"10.1016\/bs.apha.2022.11.001_bb0165","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.yjmcc.2017.07.006","article-title":"Soluble epoxide hydrolase activation by S-nitrosation contributes to cardiac ischemia-reperfusion injury","volume":"110","author":"Ding","year":"2017","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"12","key":"10.1016\/bs.apha.2022.11.001_bb0170","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1096\/fasebj.12.12.1063","article-title":"Cyclooxygenase in biology and disease","volume":"12","author":"Dubois","year":"1998","journal-title":"The FASEB Journal"},{"issue":"2","key":"10.1016\/bs.apha.2022.11.001_bb0175","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nri3800","article-title":"Role of innate and adaptive immune mechanisms in cardiac injury and repair","volume":"15","author":"Epelman","year":"2015","journal-title":"Nature Reviews. Immunology"},{"issue":"1","key":"10.1016\/bs.apha.2022.11.001_bb0180","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1038\/s41598-020-62174-w","article-title":"CYP2J2 modulates diverse transcriptional programs in adult human cardiomyocytes","volume":"10","author":"Evangelista","year":"2020","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.apha.2022.11.001_bb0185","doi-asserted-by":"crossref","first-page":"3773415","DOI":"10.1155\/2022\/3773415","article-title":"Soluble epoxide hydrolase inhibition protected against diabetic cardiomyopathy through inducing autophagy and reducing apoptosis relying on Nrf2 upregulation and transcription activation","volume":"2022","author":"Fang","year":"2022","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"6752","key":"10.1016\/bs.apha.2022.11.001_bb0190","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/46816","article-title":"Cytochrome P450 2C is an EDHF synthase in coronary arteries","volume":"401","author":"Fisslthaler","year":"1999","journal-title":"Nature"},{"issue":"6","key":"10.1016\/bs.apha.2022.11.001_bb0195","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJM200108093450607","article-title":"The coxibs, selective inhibitors of cyclooxygenase-2","volume":"345","author":"FitzGerald","year":"2001","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/bs.apha.2022.11.001_bb0200","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41569-019-0233-y","article-title":"The myth of 'stable' coronary artery disease","volume":"17","author":"Fox","year":"2020","journal-title":"Nature Reviews. Cardiology"},{"key":"10.1016\/bs.apha.2022.11.001_bb0205","doi-asserted-by":"crossref","first-page":"111149","DOI":"10.1016\/j.mce.2020.111149","article-title":"Epoxyeicosatrienoic acids improve glucose homeostasis by preventing NF-\u03baB-mediated transcription of SGLT2 in renal tubular epithelial cells","volume":"523","author":"Fu","year":"2021","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"5548","key":"10.1016\/bs.apha.2022.11.001_bb0210","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","article-title":"Prostaglandins and leukotrienes: Advances in eicosanoid biology","volume":"294","author":"Funk","year":"2001","journal-title":"Science"},{"issue":"2","key":"10.1016\/bs.apha.2022.11.001_bb0215","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbagen.2004.11.018","article-title":"Cytochrome P450 expression and catalytic activity in coronary arteries and liver of cattle","volume":"1722","author":"Grasso","year":"2005","journal-title":"Biochimica et Biophysica Acta"},{"issue":"3","key":"10.1016\/bs.apha.2022.11.001_bb0220","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.yjmcc.2006.11.020","article-title":"Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts","volume":"42","author":"Gross","year":"2007","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"3","key":"10.1016\/bs.apha.2022.11.001_bb0225","first-page":"253","article-title":"Soluble epoxide hydrolase: A new target for cardioprotection","volume":"10","author":"Gross","year":"2009","journal-title":"Current Opinion in Investigational Drugs"},{"issue":"10","key":"10.1016\/bs.apha.2022.11.001_bb0230","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1021\/cr200246d","article-title":"Lipoxygenase and leukotriene pathways: Biochemistry, biology, and roles in disease","volume":"111","author":"Haeggstrom","year":"2011","journal-title":"Chemical Reviews"},{"issue":"1","key":"10.1016\/bs.apha.2022.11.001_bb0235","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/CIRCULATIONAHA.104.527077","article-title":"Augmented cardiac hypertrophy in response to pressure overload in mice lacking the prostaglandin I2 receptor","volume":"112","author":"Hara","year":"2005","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/bs.apha.2022.11.001_bb0240","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1194\/jlr.M074229","article-title":"CYP2J2 metabolites, epoxyeicosatrienoic acids, attenuate Ang II-induced cardiac fibrotic response by targeting G\u03b1(12\/13)","volume":"58","author":"He","year":"2017","journal-title":"Journal of Lipid Research"},{"issue":"3","key":"10.1016\/bs.apha.2022.11.001_bb0245","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/cvr\/cvv018","article-title":"Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II","volume":"105","author":"He","year":"2015","journal-title":"Cardiovascular Research"},{"issue":"4","key":"10.1016\/bs.apha.2022.11.001_bb0250","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010745","article-title":"Complex role for E-Prostanoid 4 receptors in hypertension","volume":"8","author":"Herrera","year":"2019","journal-title":"Journal of the American Heart Association"},{"key":"10.1016\/bs.apha.2022.11.001_bb0255","series-title":"Myocardial Disease","article-title":"The ESC textbook of cardiovascular medicine","author":"Hess","year":"2009"},{"issue":"2","key":"10.1016\/bs.apha.2022.11.001_bb0260","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/jmcc.1999.1072","article-title":"Reduction of infarct size by selective stimulation of prostaglandin EP(3)receptors in the reperfused ischemic pig heart","volume":"32","author":"Hohlfeld","year":"2000","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/bs.apha.2022.11.001_bb0265","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.plipres.2014.11.001","article-title":"Evolutionary aspects of lipoxygenases and genetic diversity of human leukotriene signaling","volume":"57","author":"Horn","year":"2015","journal-title":"Progress in Lipid Research"},{"issue":"7","key":"10.1016\/bs.apha.2022.11.001_bb0270","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00228-017-2242-2","article-title":"The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field","volume":"73","author":"Hoxha","year":"2017","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"4","key":"10.1016\/bs.apha.2022.11.001_bb0275","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0952-3278(91)90087-L","article-title":"Gas chromatographic-mass spectrometric analysis of lipoxygenase products in post-ischemic rabbit myocardium","volume":"42","author":"Hughes","year":"1991","journal-title":"Prostaglandins, Leukotrienes, and Essential Fatty Acids"},{"issue":"21","key":"10.1016\/bs.apha.2022.11.001_bb0280","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1161\/01.CIR.0000147775.50954.AA","article-title":"Directed vascular expression of human cysteinyl leukotriene 2 receptor modulates endothelial permeability and systemic blood pressure","volume":"110","author":"Hui","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/bs.apha.2022.11.001_bb0285","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jaci.2011.11.052","article-title":"Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease","volume":"129","author":"Ingelsson","year":"2012","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"4","key":"10.1016\/bs.apha.2022.11.001_bb0290","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.3390\/ijms22041691","article-title":"Soluble epoxide hydrolase in aged female mice and human explanted hearts following ischemic injury","volume":"22","author":"Jamieson","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.apha.2022.11.001_bb0295","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pharmthera.2017.05.005","article-title":"Cytochrome P450-derived eicosanoids and heart function","volume":"179","author":"Jamieson","year":"2017","journal-title":"Pharmacology & Therapeutics"},{"issue":"3","key":"10.1016\/bs.apha.2022.11.001_bb0300","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2353\/ajpath.2008.070834","article-title":"Endothelial cysteinyl leukotriene 2 receptor expression mediates myocardial ischemia-reperfusion injury","volume":"172","author":"Jiang","year":"2008","journal-title":"The American Journal of Pathology"},{"issue":"5","key":"10.1016\/bs.apha.2022.11.001_bb0305","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1161\/01.RES.66.5.1362","article-title":"Endothelium and myocardial protecting actions of taprostene, a stable prostacyclin analogue, after acute myocardial ischemia and reperfusion in cats","volume":"66","author":"Johnson","year":"1990","journal-title":"Circulation Research"},{"issue":"2","key":"10.1016\/bs.apha.2022.11.001_bb0310","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0161-4630(81)90055-0","article-title":"Prostaglandins in myocardial: With emphasis on myocardial preservation","volume":"7","author":"Jugdutt","year":"1981","journal-title":"Prostaglandins and Medicine"},{"issue":"6","key":"10.1016\/bs.apha.2022.11.001_bb0315","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.yjmcc.2009.02.028","article-title":"Epoxyeicosatrienoic acids limit damage to mitochondrial function following stress in cardiac cells","volume":"46","author":"Katragadda","year":"2009","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"Pt A","key":"10.1016\/bs.apha.2022.11.001_bb0320","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.prostaglandins.2015.05.007","article-title":"The leukotriene B4 receptor (BLT) antagonist BIIL284 decreases atherosclerosis in ApoE\u2212\/\u2212 mice","volume":"121","author":"Ketelhuth","year":"2015","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/bs.apha.2022.11.001_bb0325","doi-asserted-by":"crossref","first-page":"4087632","DOI":"10.1155\/2016\/4087632","article-title":"Inflammatory cardiomyopathy: A current view on the pathophysiology, diagnosis, and treatment","volume":"2016","author":"Krejci","year":"2016","journal-title":"BioMed Research International"},{"key":"10.1016\/bs.apha.2022.11.001_bb0330","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev.pharmtox.45.120403.100045","article-title":"Regulation and inhibition of arachidonic acid omega-hydroxylases and 20-HETE formation","volume":"45","author":"Kroetz","year":"2005","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"5","key":"10.1016\/bs.apha.2022.11.001_bb0335","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/FPC.0b013e32809913ea","article-title":"CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: The atherosclerosis risk in communities (ARIC) study","volume":"17","author":"Lee","year":"2007","journal-title":"Pharmacogenetics and Genomics"},{"issue":"4337","key":"10.1016\/bs.apha.2022.11.001_bb0340","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1126\/science.345441","article-title":"Prostacyclin: A potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia","volume":"200","author":"Lefer","year":"1978","journal-title":"Science (New York, N.Y.)"},{"issue":"10","key":"10.1016\/bs.apha.2022.11.001_bb0345","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJM199009063231006","article-title":"Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases","volume":"323","author":"Lewis","year":"1990","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"10.1016\/bs.apha.2022.11.001_bb0350","article-title":"Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/bs.apha.2022.11.001_bb0355","doi-asserted-by":"crossref","first-page":"E270","DOI":"10.1152\/ajpendo.00118.2014","article-title":"CYP2J2 attenuates metabolic dysfunction in diabetic mice by reducing hepatic inflammation via the PPARgamma","volume":"308","author":"Li","year":"2015","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"issue":"3","key":"10.1016\/bs.apha.2022.11.001_bb0360","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11427-018-9501-9","article-title":"A life support-based comprehensive treatment regimen dramatically lowers the in-hospital mortality of patients with fulminant myocarditis: A multiple center study","volume":"62","author":"Li","year":"2019","journal-title":"Science China. Life Sciences"},{"issue":"1","key":"10.1016\/bs.apha.2022.11.001_bb0365","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/1074248416642520","article-title":"Knockout of the prostaglandin E receptor subtype 3 promotes eccentric cardiac hypertrophy and fibrosis in mice","volume":"22","author":"Liu","year":"2017","journal-title":"Journal of Cardiovascular Pharmacology and Therapeutics"},{"issue":"4\u20136","key":"10.1016\/bs.apha.2022.11.001_bb0370","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00210-007-0196-0","article-title":"Adenylyl cyclase type 6 overexpression selectively enhances beta-adrenergic and prostacyclin receptor-mediated inhibition of cardiac fibroblast function because of colocalization in lipid rafts","volume":"377","author":"Liu","year":"2008","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"issue":"22","key":"10.1016\/bs.apha.2022.11.001_bb0375","doi-asserted-by":"crossref","first-page":"9038","DOI":"10.1073\/pnas.1103482108","article-title":"Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance","volume":"108","author":"Luria","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"10.1016\/bs.apha.2022.11.001_bb0380","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1210\/en.2012-2166","article-title":"Cardiac-specific overexpression of CYP2J2 attenuates diabetic cardiomyopathy in male streptozotocin-induced diabetic mice","volume":"154","author":"Ma","year":"2013","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/bs.apha.2022.11.001_bb0385","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/CIRCRESAHA.121.320548","article-title":"Therapeutic and prognostic significance of arachidonic acid in heart failure","volume":"130","author":"Ma","year":"2022","journal-title":"Circulation Research"},{"issue":"1","key":"10.1016\/bs.apha.2022.11.001_bb0390","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1038\/s41598-018-20613-9","article-title":"2-Methoxyestradiol protects against pressure overload-induced left ventricular hypertrophy","volume":"8","author":"Maayah","year":"2018","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/bs.apha.2022.11.001_bb0395","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1073\/pnas.96.1.272","article-title":"Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2","volume":"96","author":"McAdam","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/bs.apha.2022.11.001_bb0400","doi-asserted-by":"crossref","first-page":"H679","DOI":"10.1152\/ajpheart.00533.2009","article-title":"Inhibition of soluble epoxide hydrolase preserves cardiomyocytes: Role of STAT3 signaling","volume":"298","author":"Merkel","year":"2010","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"8","key":"10.1016\/bs.apha.2022.11.001_bb0405","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/bph.14167","article-title":"Eicosanoids, prostacyclin and cyclooxygenase in the cardiovascular system","volume":"176","author":"Mitchell","year":"2019","journal-title":"British Journal of Pharmacology"},{"issue":"7","key":"10.1016\/bs.apha.2022.11.001_bb0410","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.tcm.2008.11.009","article-title":"Endothelial cysteinyl leukotriene 2 receptor expression and myocardial ischemia\/reperfusion injury","volume":"18","author":"Moos","year":"2008","journal-title":"Trends in Cardiovascular Medicine"},{"key":"10.1016\/bs.apha.2022.11.001_bb0415","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1146\/annurev-pharmtox-011112-140244","article-title":"Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health","volume":"53","author":"Morisseau","year":"2013","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"5","key":"10.1016\/bs.apha.2022.11.001_bb0420","doi-asserted-by":"crossref","first-page":"H2128","DOI":"10.1152\/ajpheart.00428.2008","article-title":"Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo","volume":"295","author":"Motoki","year":"2008","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"5","key":"10.1016\/bs.apha.2022.11.001_bb0425","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.cmet.2019.01.005","article-title":"Glycogen synthase kinase-3alpha promotes fatty acid uptake and Lipotoxic cardiomyopathy","volume":"29","author":"Nakamura","year":"2019","journal-title":"Cell Metabolism"},{"issue":"1","key":"10.1016\/bs.apha.2022.11.001_bb0430","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI200113455","article-title":"Genetic and pharmacological analysis of prostanoid receptor function","volume":"108","author":"Narumiya","year":"2001","journal-title":"The Journal of Clinical Investigation"},{"issue":"2","key":"10.1016\/bs.apha.2022.11.001_bb0435","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cardiores.2005.10.001","article-title":"The role of natriuretic peptides in cardioprotection","volume":"69","author":"Nishikimi","year":"2006","journal-title":"Cardiovascular Research"},{"issue":"5431","key":"10.1016\/bs.apha.2022.11.001_bb0440","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.285.5431.1276","article-title":"Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids","volume":"285","author":"Node","year":"1999","journal-title":"Science"},{"issue":"1","key":"10.1016\/bs.apha.2022.11.001_bb0445","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1194\/jlr.M061697","article-title":"Cytochrome P450-derived epoxyeicosatrienoic acids and coronary artery disease in humans: A targeted metabolomics study","volume":"57","author":"Oni-Orisan","year":"2016","journal-title":"Journal of Lipid Research"},{"issue":"5","key":"10.1016\/bs.apha.2022.11.001_bb0450","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1378\/chest.121.5.1638","article-title":"Alcoholic cardiomyopathy: Incidence, clinical characteristics, and pathophysiology","volume":"121","author":"Piano","year":"2002","journal-title":"Chest"},{"issue":"4","key":"10.1016\/bs.apha.2022.11.001_bb0455","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bbalip.2014.08.012","article-title":"5-lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease","volume":"1851","author":"Radmark","year":"2015","journal-title":"Biochimica et Biophysica Acta"},{"issue":"5 Suppl","key":"10.1016\/bs.apha.2022.11.001_bb0460","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.2223\/JPED.1553","article-title":"Antileukotrienes in the treatment of asthma and allergic rhinitis","volume":"82","author":"Ribeiro","year":"2006","journal-title":"Jornal de Pediatria"},{"issue":"9","key":"10.1016\/bs.apha.2022.11.001_bb0465","doi-asserted-by":"crossref","first-page":"H1020","DOI":"10.1152\/ajpheart.00465.2014","article-title":"Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice","volume":"308","author":"Roche","year":"2015","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"2","key":"10.1016\/bs.apha.2022.11.001_bb0470","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0005-2760(95)00216-2","article-title":"Synthesis of hydroxyeicosatetraenoic (HETEs) and epoxyeicosatrienoic acids (EETs) by cultured bovine coronary artery endothelial cells","volume":"1299","author":"Rosolowsky","year":"1996","journal-title":"Biochimica et Biophysica Acta"},{"issue":"2 Pt 2","key":"10.1016\/bs.apha.2022.11.001_bb0475","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1164\/ajrccm.161.supplement_1.ltta-1","article-title":"The discovery of the leukotrienes","volume":"161","author":"Samuelsson","year":"2000","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"4","key":"10.1016\/bs.apha.2022.11.001_bb0480","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1476-5381.1986.tb14579.x","article-title":"Treatment of acute myocardial ischaemia with a selective antagonist of thromboxane receptors (BM 13.177)","volume":"87","author":"Schr\u00f6r","year":"1986","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2022.11.001_bb0485","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1006\/bbrc.1998.8461","article-title":"Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice","volume":"246","author":"Segi","year":"1998","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"5","key":"10.1016\/bs.apha.2022.11.001_bb0490","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1161\/01.RES.0000139436.89654.c8","article-title":"Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42\/p44 MAPK pathway","volume":"95","author":"Seubert","year":"2004","journal-title":"Circulation Research"},{"issue":"1","key":"10.1016\/bs.apha.2022.11.001_bb0495","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/03602532.2013.837916","article-title":"Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids","volume":"46","author":"Shahabi","year":"2014","journal-title":"Drug Metabolism Reviews"},{"issue":"12","key":"10.1016\/bs.apha.2022.11.001_bb0500","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1073\/pnas.83.12.4175","article-title":"Characterization of leukotriene A4 synthase from murine mast cells: Evidence for its identity to arachidonate 5-lipoxygenase","volume":"83","author":"Shimizu","year":"1986","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1016\/bs.apha.2022.11.001_bb0505","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000312669","article-title":"Cysteinyl leukotrienes and their receptors: Molecular and functional characteristics","volume":"85","author":"Singh","year":"2010","journal-title":"Pharmacology"},{"issue":"14","key":"10.1016\/bs.apha.2022.11.001_bb0510","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1073\/pnas.1221972110","article-title":"Unique mechanistic insights into the beneficial effects of soluble epoxide hydrolase inhibitors in the prevention of cardiac fibrosis","volume":"110","author":"Sirish","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.apha.2022.11.001_bb0515","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","article-title":"Cyclooxygenases: Structural, cellular, and molecular biology","volume":"69","author":"Smith","year":"2000","journal-title":"Annual Review of Biochemistry"},{"issue":"10","key":"10.1016\/bs.apha.2022.11.001_bb0520","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1021\/cr2002992","article-title":"Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis","volume":"111","author":"Smith","year":"2011","journal-title":"Chemical Reviews"},{"issue":"3","key":"10.1016\/bs.apha.2022.11.001_bb0525","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1124\/jpet.109.157545","article-title":"Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice","volume":"331","author":"Sodhi","year":"2009","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"11","key":"10.1016\/bs.apha.2022.11.001_bb0530","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.3390\/ijms19113285","article-title":"Arachidonic acid metabolites in cardiovascular and metabolic diseases","volume":"19","author":"Sonnweber","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/bs.apha.2022.11.001_bb0535","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0163-7827(03)00049-3","article-title":"Epoxyeicosatrienoic acids (EETs): Metabolism and biochemical function","volume":"43","author":"Spector","year":"2004","journal-title":"Progress in Lipid Research"},{"issue":"2","key":"10.1016\/bs.apha.2022.11.001_bb0540","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/01.HYP.0000254415.31362.a7","article-title":"Role of oxidative stress in cardiac hypertrophy and remodeling","volume":"49","author":"Takimoto","year":"2007","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/bs.apha.2022.11.001_bb0545","doi-asserted-by":"crossref","first-page":"50","DOI":"10.15420\/ecr.2018.33.1","article-title":"The role of inflammation in diabetes: Current concepts and future perspectives","volume":"14","author":"Tsalamandris","year":"2019","journal-title":"European Cardiology"},{"key":"10.1016\/bs.apha.2022.11.001_bb0550","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.prostaglandins.2015.04.003","article-title":"A potential role of PUFAs and COXIBs in cancer chemoprevention","volume":"120","author":"Vara-Messler","year":"2015","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/bs.apha.2022.11.001_bb0555","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pharmthera.2017.06.006","article-title":"Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases","volume":"180","author":"Wagner","year":"2017","journal-title":"Pharmacology & Therapeutics"},{"issue":"14","key":"10.1016\/bs.apha.2022.11.001_bb0560","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1089\/scd.2016.0072","article-title":"Epoxyeicosatrienoic acids regulate adipocyte differentiation of mouse 3T3 cells, via PGC-1\u03b1 activation, which is required for HO-1 expression and increased mitochondrial function","volume":"25","author":"Waldman","year":"2016","journal-title":"Stem Cells and Development"},{"issue":"1","key":"10.1016\/bs.apha.2022.11.001_bb0565","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1124\/mol.113.087122","article-title":"CYP2J2-derived epoxyeicosatrienoic acids suppress endoplasmic reticulum stress in heart failure","volume":"85","author":"Wang","year":"2014","journal-title":"Molecular Pharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2022.11.001_bb0570","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1124\/jpet.105.083477","article-title":"Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase\/Akt signaling pathways","volume":"314","author":"Wang","year":"2005","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1","key":"10.1016\/bs.apha.2022.11.001_bb0575","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: Mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"5","key":"10.1016\/bs.apha.2022.11.001_bb0580","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/acel.12507","article-title":"CYP2J2 and its metabolites (epoxyeicosatrienoic acids) attenuate cardiac hypertrophy by activating AMPK\u03b12 and enhancing nuclear translocation of Akt1","volume":"15","author":"Wang","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/bs.apha.2022.11.001_bb0585","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.yjmcc.2020.12.013","article-title":"Soluble epoxide hydrolase deficiency attenuates lipotoxic cardiomyopathy via upregulation of AMPK-mTORC mediated autophagy","volume":"154","author":"Wang","year":"2020","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"6","key":"10.1016\/bs.apha.2022.11.001_bb0590","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.3390\/cells9061391","article-title":"Bioactive lipid signaling in cardiovascular disease, development, and regeneration","volume":"9","author":"Wasserman","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/bs.apha.2022.11.001_bb0595","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1161\/01.RES.88.1.70","article-title":"Overexpression of 12-lipoxygenase causes cardiac fibroblast cell growth","volume":"88","author":"Wen","year":"2001","journal-title":"Circulation Research"},{"issue":"16","key":"10.1016\/bs.apha.2022.11.001_bb0600","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.1016\/S0021-9258(19)43558-8","article-title":"On the organization and mechanism of prostaglandin synthetase","volume":"248","author":"Wlodawer","year":"1973","journal-title":"The Journal of Biological Chemistry"},{"issue":"19","key":"10.1016\/bs.apha.2022.11.001_bb0605","doi-asserted-by":"crossref","first-page":"12551","DOI":"10.1074\/jbc.272.19.12551","article-title":"Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes","volume":"272","author":"Wu","year":"1997","journal-title":"The Journal of Biological Chemistry"},{"issue":"20","key":"10.1016\/bs.apha.2022.11.001_bb0610","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1161\/01.CIR.0000128046.54681.97","article-title":"Prostaglandin E2 protects the heart from ischemia-reperfusion injury via its receptor subtype EP4","volume":"109","author":"Xiao","year":"2004","journal-title":"Circulation"},{"issue":"49","key":"10.1016\/bs.apha.2022.11.001_bb0615","doi-asserted-by":"crossref","first-page":"18733","DOI":"10.1073\/pnas.0609158103","article-title":"Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors","volume":"103","author":"Xu","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"10.1016\/bs.apha.2022.11.001_bb0620","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1210\/en.2012-2012","article-title":"CYP2J3 gene delivery up-regulated adiponectin expression via reduced endoplasmic reticulum stress in adipocytes","volume":"154","author":"Xu","year":"2013","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/bs.apha.2022.11.001_bb0625","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.addr.2011.03.006","article-title":"The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases","volume":"63","author":"Xu","year":"2011","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"4","key":"10.1016\/bs.apha.2022.11.001_bb0630","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2337\/db09-1241","article-title":"Increased CYP2J3 expression reduces insulin resistance in fructose-treated rats and db\/db mice","volume":"59","author":"Xu","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/bs.apha.2022.11.001_bb0635","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.prostaglandins.2015.01.004","article-title":"CYP epoxygenase 2J2 prevents cardiac fibrosis by suppression of transmission of pro-inflammation from cardiomyocytes to macrophages","volume":"116\u2013117","author":"Yang","year":"2015","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/bs.apha.2022.11.001_bb0640","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.semcancer.2016.02.001","article-title":"Targeting arachidonic acid pathway by natural products for cancer prevention and therapy","volume":"40\u201341","author":"Yarla","year":"2016","journal-title":"Seminars in Cancer Biology"},{"issue":"5","key":"10.1016\/bs.apha.2022.11.001_bb0645","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/01.HYP.30.5.1047","article-title":"Prostacyclin release by rat cardiac fibroblasts: Inhibition of collagen expression","volume":"30","author":"Yu","year":"1997","journal-title":"Hypertension (Dallas, Tex.: 1979)"},{"issue":"2 Suppl","key":"10.1016\/bs.apha.2022.11.001_bb0650","first-page":"19","article-title":"Roles of prostanoids in the pathogenesis of cardiovascular diseases","volume":"29","author":"Yuhki","year":"2010","journal-title":"International Angiology : A Journal of the International Union of Angiology"},{"issue":"2","key":"10.1016\/bs.apha.2022.11.001_bb0655","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharmthera.2010.09.004","article-title":"Roles of prostanoids in the pathogenesis of cardiovascular diseases: Novel insights from knockout mouse studies","volume":"129","author":"Yuhki","year":"2011","journal-title":"Pharmacology & Therapeutics"},{"issue":"9","key":"10.1016\/bs.apha.2022.11.001_bb0660","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1161\/01.ATV.19.9.2141","article-title":"Selective activation of the prostanoid EP(3) receptor reduces myocardial infarct size in rodents","volume":"19","author":"Zacharowski","year":"1999","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"1","key":"10.1016\/bs.apha.2022.11.001_bb0665","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0014-2999(98)00963-7","article-title":"Reduction of myocardial injury by the EP3 receptor agonist TEI-3356. Role of protein kinase C and of K(ATP)-channels","volume":"367","author":"Zacharowski","year":"1999","journal-title":"European Journal of Pharmacology"},{"issue":"39","key":"10.1016\/bs.apha.2022.11.001_bb0670","doi-asserted-by":"crossref","first-page":"36059","DOI":"10.1074\/jbc.R100030200","article-title":"Epoxygenase pathways of arachidonic acid metabolism","volume":"276","author":"Zeldin","year":"2001","journal-title":"The Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/bs.apha.2022.11.001_bb716","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1210\/endo.138.3.4970","article-title":"Predominant expression of an arachidonate epoxygenase in islets of Langerhans cells in human and rat pancreas","volume":"138","author":"Zeldin","year":"1997","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/bs.apha.2022.11.001_bb0675","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1124\/mol.51.6.931","article-title":"CYP2J subfamily cytochrome P450s in the gastrointestinal tract: Expression, localization, and potential functional significance","volume":"51","author":"Zeldin","year":"1997","journal-title":"Molecular Pharmacology"},{"issue":"5","key":"10.1016\/bs.apha.2022.11.001_bb0680","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0026-895X(25)09539-2","article-title":"CYP2J subfamily P450s in the lung: Expression, localization, and potential functional significance","volume":"50","author":"Zeldin","year":"1996","journal-title":"Molecular Pharmacology"},{"issue":"10","key":"10.1016\/bs.apha.2022.11.001_bb0685","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1194\/jlr.M053199","article-title":"Functional characterization of cytochrome P450-derived epoxyeicosatrienoic acids in adipogenesis and obesity","volume":"55","author":"Zha","year":"2014","journal-title":"Journal of Lipid Research"},{"issue":"1","key":"10.1016\/bs.apha.2022.11.001_bb0690","doi-asserted-by":"crossref","first-page":"H37","DOI":"10.1152\/ajpheart.00983.2008","article-title":"Overexpression of CYP2J2 provides protection against doxorubicin-induced cardiotoxicity","volume":"297","author":"Zhang","year":"2009","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"10","key":"10.1016\/bs.apha.2022.11.001_bb0695","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1089\/ars.2020.8105","article-title":"Interplay between oxidative stress, cyclooxygenases, and Prostanoids in cardiovascular diseases","volume":"34","author":"Zhao","year":"2021","journal-title":"Antioxidants & Redox Signaling"},{"key":"10.1016\/bs.apha.2022.11.001_bb0700","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.yjmcc.2018.08.027","article-title":"Endothelium-specific CYP2J2 overexpression improves cardiac dysfunction by promoting angiogenesis via Jagged1\/Notch1 signaling","volume":"123","author":"Zhao","year":"2018","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"3","key":"10.1016\/bs.apha.2022.11.001_bb0705","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1194\/jlr.M017319","article-title":"Epoxyeicosatrienoic acids protect rat hearts against tumor necrosis factor-alpha-induced injury","volume":"53","author":"Zhao","year":"2012","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/bs.apha.2022.11.001_bb0710","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.freeradbiomed.2018.02.009","article-title":"CYP2J2-derived EETs attenuated ethanol-induced myocardial dysfunction through inducing autophagy and reducing apoptosis","volume":"117","author":"Zhou","year":"2018","journal-title":"Free Radical Biology & Medicine"}],"container-title":["Advances in Pharmacology","Bioactive Lipid Mediators in Cardiopulmonary Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358922000825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358922000825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T16:26:43Z","timestamp":1762360003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054358922000825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9780323950572"],"references-count":142,"URL":"https:\/\/doi.org\/10.1016\/bs.apha.2022.11.001","relation":{},"ISSN":["1054-3589"],"issn-type":[{"value":"1054-3589","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}